Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

Item
http://www.wikidata.org/entity/Q37747570
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Factors affecting hospital stay in psychiatric patients: the role of active comorbidity.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trialsProlactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network.The Correlation between Osteoporosis Occurrences in Both Schizophrenia and Parkinson's Disease.Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.An updated view of hypothalamic-vascular-pituitary unit function and plasticity.Basic treatment principles for psychotic disorders in patients with epilepsy.Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone.Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications.Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China.Clinical Management of Antipsychotic-Induced Hyperprolactinemia.Management of common adverse effects of antipsychotic medications
P2860

Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

Item
http://www.wikidata.org/entity/Q37747570
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@en
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@nl
type
label
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@en
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@nl
prefLabel
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@en
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2265.2010.03814.X
P433
P478
P50
P577
P5875
P698